Estrogen

Estrogens are a group of steroid hormones, primarily estradiol (E2), estrone (E1), and estriol (E3), produced mainly in the ovaries (premenopause), adipose tissue (postmenopause), and placenta (pregnancy). Estradiol is the most potent form during reproductive years. Beyond reproductive function, estrogens affect neurotransmitter systems (serotonin, dopamine, GABA), bone density, cardiovascular function, cognitive performance, and mood regulation through receptors in virtually every tissue.

Dramatic estrogen shifts drive several clinically relevant states. Postpartum estradiol drops from 15,000-30,000 pg/mL in late pregnancy to near-premenopausal levels within 24-48 hours of delivery, contributing to postpartum depression vulnerability and cognitive symptoms. Perimenopausal fluctuation (2-8 years before final menstrual period) produces vasomotor symptoms, sleep disruption, mood changes, and cognitive symptoms as estradiol swings unpredictably before its final decline. Menstrual cycle fluctuation affects mood and cognition in approximately 5-8% of reproductive-age women severely enough to meet criteria for premenstrual dysphoric disorder.

Nutritional modulation of estrogen biology is possible but limited in scope. Phytoestrogens (soy isoflavones, red clover, flaxseed lignans) bind estrogen receptors with 100-1000 times lower affinity than endogenous estradiol, producing weak agonist or partial antagonist effects depending on receptor subtype and local estrogen concentration. They modestly reduce vasomotor symptoms with effect sizes substantially smaller than hormone replacement therapy. DIM (diindolylmethane) and I3C (indole-3-carbinol) from cruciferous vegetables support estrogen metabolism toward less proliferative pathways, with evidence strongest for cyclical breast tenderness and fibrocystic changes. These interventions are not replacements for HRT in symptomatic perimenopause or menopause.